egypt gastrointestinal diseases drug market

Egypt Gastrointestinal Diseases Drug Market: Segmentation by Drug Type (Antacids, Antiulcerants, Vitamin and Minerals, Antiobesity, Antiemetics and Antinauseants, Antidiarrhoeals), Drug Classification (Branded and Generic), Route of Administration (Oral, Parenteral, Others), Mode of Purchase (Prescription Based Drugs, Over-the-counter Drugs), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) - Trends, And Forecasts (2019 2028)

  • Published Date: 2022-12-28
  • Report ID: 140091
  • Pages: 200
  • Format: prudent report format

Egypts Gastrointestinal diseases drugs market size stood at USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

Gastrointestinal diseases are defined as the condition or disease that occurs within the gastrointestinal tract. Constipation, Irritable Bowel Syndrome, Colitis, Inflammatory Bowel Disease etc. are some of the common gastrointestinal disorders. Patients with gastrointestinal disorders may experience cramps and pain in the abdomen, bloating and change in bowel habits.

According to recent statistics by the World Health Organization (WHO), the annual mortality rate associated with diarrhoea is 30 deaths per 100,000 among Egyptian children under five years old. Nearly 3.9% of reported deaths are due to rotavirus infection, whereas enteric adenovirus is the second leading cause of acute diarrhoea after rotavirus. Both viruses, as extremely etiological agents for diarrhoea, constitute a major health problem in developing countries.



Market Drivers

The increasing prevalence of GI diseases, such as inflammatory bowel disease (IBD) and ulcerative colitis, is one of the key factors driving the growth of the market. Due to changing lifestyle patterns and unhealthy dietary habits, there is an increased probability of disease recurrence among patients.

Furthermore, the rising geriatric population of Egypt, which is more susceptible to such ailments, is also driving the market growth. Various technological advancements, such as the development of innovative biosimilars and cellular therapies for the treatment of the disorder, are acting as other growth-inducing factors. These biologics are administered through intravenous and subcutaneous injections and are personalized for targeted treatments.

Other factors, including rising health consciousness among the masses, extensive research and development (R&D) activities and significant improvements in the healthcare infrastructure, especially in developing economies such as Egypt, are anticipated to drive the market further.


1. Gastrointestinal Disease Drug Market Overview..........................
A. Market Size
2. Market Growth Drivers.
A. Increase in Prevalence Due to Unhealthy Dietary Habits
B. Rise in Geriatric Population
C. Technological Advancements
D. Rise in Awareness
3. Major Types of Gastrointestinal Diseases
A. Gastroenteritis
B. Inflammatory Bowel Disease (IBD)
C. Irritable Bowel Syndrome
D. Others
4. Gastrointestinal Diseases Drug Market Segmentation........
A. Drug Type
I. Antacids
II. Antiulcerants
III. Vitamin and Minerals
IV. Antiobesity
V. Antiemetics and Antinauseants
VI. Antidiarrhoeals
B. Drug Classification
I. Branded Drugs
II. Generic Drugs
C. Route of Administration
I. Oral
II. Parenteral
III. Others
D. Mode of Purchase
I. Prescription-Based Drugs
II. Over-The-Counter Drugs
E. Distribution Channel
I. Hospital Pharmacies
II. Retail Pharmacies
III. Online Pharmacies
5. Gastrointestinal Diseases Major Drugs Market Share..
A. Market Analysis, Insights and Forecast By Revenue
6. Competitive Landscape...
A. Major Players
B. Products in Pipeline
7. Key Company Profiles..
A. Amoun Pharmaceutical Company overview, Product & Services, Strategies & Financials
B. AstraZeneca Company overview, Product & Services, Strategies & Financials
C. GSK Company, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape.
A. Policy changes and Reimbursement scenario
9. Factors Driving Future Growth.
A. New Trends and Development of Gastrointestinal disease drug market
B. Future Opportunities
10. Conclusion
CHOOSE LICENCE TYPE
prudent payment methods
Contact Us

Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071

Drop us an email at
sales@prudentmarkets.com

Why Choose Us
24 * 7 Access to Analyst :

Get your pre and post sales queries resolved by our Subject matter experts.

Customization :

We will assist you to customize the report to fit your research needs.

Assured Quality :

Our prime focus is to provide qualitative and accurate data.

Free sample report :

Feel free to order a sample report before purchase.

Security :

Your personal and confidential information is safe and secured.